DEFOPHARMA
Timeline
9 events since 2019Filings
Financial
Establishments
2020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBabbreviated format · 83 days late
Registered in the Peppol Directory Reachable for e-invoices through 0208:0732501933
2025
Annual accounts 2024 filed PDFfull format · 61 days late
2024
Highest result from 2020 to 2025 net €18,613 ▲15.8% The net result of €18,613 is the highest of those years.
Annual accounts 2023 filed PDFfull format · 77 days late
2022
Annual accounts 2021 filed PDFmicro format · 44 days before the deadline
2021
Annual accounts 2020 filed PDFmicro format · 27 days late
2019
First establishment Raadstraat 44, Ixelles
IncorporationFounding capital of €12,400, 124 shares · Appointment: Djouguela Defo (director) · published on 13-08-20192 points ▸
- Founding capital, €12,400, 124 shares
- Director appointment, Djouguela Defo (director (not named in the articles))
- The deed holds 1 more point.
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
DEFOPHARMA was incorporated on 9 August 2019 as a private limited company, with a starting capital of €12,400.12 Djouguela Defo is director of the company, appointed by deed of 13-08-2019.2 Total assets rose from €147,141 in 2020 to €181,427 in 2025.3